(The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Discover the latest trends in the business world, from Barnes and Noble's growth fueled by BookTok to the FDA's approval of a new nonopioid pain medication.

More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...

Meloxicam is a non-steroidal, anti-inflammatory molecule developed with Axsome’s Molecular Solubility Enhanced Inclusion ...

Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...

On Thursday, in a major step forward in pain management, the U.S. Food and Drug Administration has approved a new nonopioid ...

Plus, NBC News spoke to trans service members about their thoughts on President Trump's executive order banning trans people from enlisting and serving in the military.

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.